Global Thyroid Cancer Drug Market Set to Grow at Healthy CAGR of 24.3 % by 2026

This comprehensive Thyroid Cancer Drug Market report underlines the primary and secondary drivers, market share, possible sales volume, leading segments and geographical analysis. Have your business at the highest level of growth with this all-inclusive Thyroid Cancer Drug Market research report. Moreover, this market research report puts forth thorough overview of the market where it identifies industry trends, determines brand awareness and influence, provides industry insights and offers competitive intelligence. The report precisely collects the information about effective factors for the Healthcare industry which includes customer behaviour, emerging trends, product usage, and brand positioning.

Global thyroid cancer drug market is rise gradually to an estimated value of USD 2404.8 million by 2026 registering a CAGR of 24.3% in the forecast period of 2019-2026.

Browse full report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-thyroid-cancer-drug-marketMarket Definition: Global Thyroid Cancer Drug Market

Thyroid cancer is also known as thyroid nodules is a cancer occur in thyroid gland and can spread to other parts of the body and about 90% of all thyroid cancers are benign.

According to the statistics published in American Cancer Society 2019, it is estimated that 52,070 patients to be diagnosed with thyroid cancer in the United States in this current year. It is more prevalent in women and near 2% of cases occurs in children. Growing population of thyroid cancer and adopting unhealthy life style are the key factors for market growth.

Market Drivers

• Increase in prevalence rate of neuroendocrine tumor worldwide
• Accelerating demand of treatment and novel therapies
• Rising awareness about treatment and technological advancement is driving the growth of market
• Increases cases of obesity and adopting unhealthy life style

Market Restraints

• Effective treatment is either unavailable or unaffordable
• Patent expiry of the patented drugs and introduction of generic version of branded drugs is expected to restrain the growth if the market
• Inadequate awareness about thyroid cancer treatment in some developing countries

Segmentation: Global Thyroid Cancer Drug Market

By Type

• Papillary thyroid cancer
• Follicular thyroid cancer
• Hurthle cell cancer
• Medullary thyroid cancer (MTC)
• Anaplastic thyroid cancer

By Drug Type

• Thyroid desiccated
• Sorafenib
• Thyrotropin alfa
• Vandetanib
• Doxorubicin
• Cabozantinib
• Lenvatinib
• Sodium iodide I-131
• Dabrafenib
• Trametinib
• Others

By Treatment

• Medication
• Chemotherapy
• Radioactive iodine (radioiodine) therapy
• Hormone therapy
• Surgery
  • Lobectomy
  • Near-total thyroidectomy
  • Total thyroidectomy

By Route of administration

• Oral
• Injectable
• Others

By End users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Key Developments in the Market:

• In May 2018, Novartis AG received FDA approval for Tafinlar in combination with Mekinist (trametinib) for the treatment of anaplastic thyroid cancer comprising of abnormal gene known as BRAF V600E
• In March 2018, Eisai Co., Ltd and Merck & Co., Inc entered into research collaboration for exclusive worldwide co-development and co- commercialization of Lenvima in combination with pembrolizumab for 11 potential indications in six types of cancer (endometrial cancer, non-small cell lung cancer, hepatocellular carcinoma, head and neck cancer, bladder cancer and melanoma). Lenvima has been approved from the FDA for the treatment of differentiated thyroid cancer

Competitive Analysis: Global Thyroid Cancer Drug Market

Global thyroid cancer drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of thyroid cancer drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster